000 01868cam  2200337zi 4500
0019.933579
003CaOODSP
00520240222113043
006m     o  d f      
007cr cn|||||||||
008240207e202201  oncd    ob   f000 0 eng d
040 |aCaOODSP|beng|erda|cCaOODSP
043 |an-cn---
0861 |aHP5-213/2022E-PDF
24500|aEvaluation of PHAC's activities for the federal framework on lyme disease and action plan : |breport / |cprepared by the Office of Audit and Evaluation Public Health Agency of Canada and Health Canada.
264 1|a[Ottawa] : |b[Public Health Agency of Canada and Health Canada], |cJanuary 2022.
300 |a1 online resource (iii, 42, xvi pages) : |bgraphs
336 |atext|btxt|2rdacontent
337 |acomputer|bc|2rdamedia
338 |aonline resource|bcr|2rdacarrier
500 |aIssued also in French under title: Évaluation des activités de l’ASPC liées au Cadre fédéral relatif à la maladie de Lyme et au Plan d’action connexe : rapport.
504 |aIncludes bibliographical references (pages xii-xvi).
61020|aPublic Health Agency of Canada|xEvaluation.
650 0|aLyme disease|zCanada|xPrevention|xEvaluation.
650 0|aLyme disease|xPrevention|xGovernment policy|zCanada.
7102 |aPublic Health Agency of Canada, |eissuing body.
7101 |aCanada. |bHealth Canada, |eissuing body.
77508|tÉvaluation des activités de l’ASPC liées au Cadre fédéral relatif à la maladie de Lyme et au Plan d’action connexe : |w(CaOODSP)9.934338
85640|qPDF|s928 KB|uhttps://publications.gc.ca/collections/collection_2024/aspc-phac/HP5-213-2022-eng.pdf
8564 |qHTML|sN/A|uhttps://www.canada.ca/en/public-health/corporate/transparency/corporate-management-reporting/evaluation/activities-federal-framework-lyme-disease-action-plan.html